Form 4: Merck Director Mary Ellen Coe Reports Acquisition of Common Stock and Phantom Stock Units

Merck & Co., Inc. Director Mary Ellen Coe has reported the acquisition of 10 shares of common stock and 2,863.0921 phantom stock units, increasing her beneficial ownership.

Summary

• Mary Ellen Coe, a Director of Merck & Co., Inc. (MRK), filed a Form 4 reporting changes in her beneficial ownership.
• On May 30, 2025, Ms. Coe acquired 10 shares of Merck & Co., Inc. Common Stock through a direct ownership form.
• Additionally, on May 30, 2025, she acquired 2,863.0921 phantom stock units at a price of $76.84 per unit.
• These phantom stock units are convertible on a 1-for-1 basis into common stock equivalents.
• The phantom stock units are designated to be settled 100% in cash upon Ms. Coe's termination of service, in accordance with a distribution schedule elected under the Plan for Deferred Payment of Directors' Compensation.
• Following these reported transactions, Ms. Coe's beneficial ownership of phantom stock units totals 27,672.774 units.
• Her reported holdings also include shares acquired through dividend reinvestment transactions.

Sentiment

Score: 7

Explanation: The acquisition of common stock and phantom stock units by a director is generally viewed as a positive signal, indicating alignment of interests with shareholders and confidence in the company's future.

Positives

• Director Mary Ellen Coe acquired 10 shares of Merck & Co., Inc. common stock, indicating a direct investment in the company.
• The acquisition of 2,863.0921 phantom stock units increases the director's overall beneficial ownership in the company, further aligning her interests with shareholders.

Negatives

• No explicit negative information was reported in this Form 4 filing.

Risks

• This Form 4 filing does not contain information regarding specific company risks.

Future Outlook

This Form 4 filing does not contain forward-looking statements or guidance.

Industry Context

This Form 4 filing details an individual insider transaction and does not provide broader industry context or trends.

Comparison to Industry Standards

• This document, an insider trading report (Form 4), does not provide information suitable for comparison to industry standards or global benchmarks.

Related Party Transactions

• The phantom stock units are part of a Plan for Deferred Payment of Directors' Compensation, which is a standard arrangement for director remuneration.

Stakeholder Impact

• Shareholders may view the director's acquisition of shares and phantom stock units as a positive sign of confidence in the company's future performance.

Next Steps

• This Form 4 filing does not outline specific future actions, events, or milestones.

Key Dates

Keywords

Merck, MRK, Form 4, Insider Trading, Director, Stock Acquisition, Phantom Stock, Beneficial Ownership, SEC Filing